Skip to content

Released Aug 14, 2018, after the close

10-Q filed Aug 14, 2018, 45 days after period end · 0001390478-18-000022

Q2 2018 · 10-Q
Revenue—
Net Income-$6.06MN/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$1.26N/M vs Q2 2017N/M vs Q1 2018
Operating Cash Flowderived-$6,299,000N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2018Q2 2017Q2 2016Q2 2013
Revenue———$3.38M
Net Income-$6.06M-$5.91M$5.39M$5.39M
EPS Diluted-$1.26-$0.22$0.58-$0.11

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR